Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/27624

Title: MUC1 (EMA) expressing plasma cells in bone marrow infiltrated by plasma cell myeloma
Issue Date: 2007
Publisher: Murcia : F. Hernández
ISSN: 0213-3911
Related subjects: 616 - Patología. Medicina clínica. Oncología
Keywords: Plasma cell
Myeloma
Abstract: MUC1 (also called: epithelial membrane antigen, EMA) represents a mucin molecule strongly expressed in various epithelia and epithelial neoplasms. Its expression correlates with clinical and pathological factors as well as prognosis in some tumor types. Additionally, MUC1 was detected in normal haematopoietic cell lines and neoplasms, especially subgroups of human lymphomas including plasma cell myeloma. Therefore, the expression of MUC1 in trephine biopsies exhibiting infiltrates of plasma cell myeloma were investigated immunohistochemically. An immunoreactivity of two monoclonal antibodies (EMA and HMFG-2) was observed in about 50% of the cases. In cases exhibiting a so-called packed marrow, EMA immunoreactivity was reduced. However, MUC1 positivity did not correlate with the cytologic grade of differentiation, the fibre content of the marrow, or survival probability of the patients. However, its strong expression in a certain percentage of cases of plasma cell myeloma may be of therapeutic impact, since new therapeutic strategies include the enrichment of MUC1- specific T cells or MUC1 vaccination.
Primary author: Baldus, S.E.
Palmen, C.
Thiele, J.
Published in: Histology and histopathology
URI: http://hdl.handle.net/10201/27624
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 5
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.22, nº 8 (2007)

Files in This Item:
File Description SizeFormat 
MUC1 EMA expressing plasma cells in bone marrow infiltrated by plasma cell myeloma.pdf542,74 kBAdobe PDFThumbnail
View/Open


Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.